Scholars@Duke

• Background
• 

  Education, Training, & Certifications

  • M.D., University of North Carolina at Chapel Hill 1976
• 

  Duke Appointment History

  • Adjunct Associate Professor of Psychiatry and Behavioral Sciences, Psychiatry & Behavioral Sciences, General Psychiatry, Psychiatry & Behavioral Sciences 2013 - 2017
  • Adjunct Associate Professor of Psychiatry and Behavioral Sciences, Psychiatry & Behavioral Sciences, Medical Psychology, Psychiatry & Behavioral Sciences 2006 - 2013
  • Adjunct Assistant Professor of Psychiatry and Behavioral Sciences, Psychiatry & Behavioral Sciences, Translational Neuroscience, Psychiatry & Behavioral Sciences 2002 - 2006
  • Adjunct Associate in Psychiatry and Behavioral Sciences, Psychiatry & Behavioral Sciences, Translational Neuroscience, Psychiatry & Behavioral Sciences 1994 - 2002
• Publications & Artistic Works
• 

  Selected Publications

  • Academic Articles

    • Weisler, Richard H., Michael Greenbaum, Valerie Arnold, Ming Yu, Brian Yan, Margo Jaffee, and Brigitte Robertson. “Efficacy and Safety of SHP465 Mixed Amphetamine Salts in the Treatment of Attention-Deficit/Hyperactivity Disorder in Adults: Results of a Randomized, Double-Blind, Placebo-Controlled, Forced-Dose Clinical Study..” Cns Drugs 31, no. 8 (August 2017): 685–97. https://doi.org/10.1007/s40263-017-0455-7.
       Full Text
    • Weisler, Richard H., Ai Ota, Kana Tsuneyoshi, Pamela Perry, Emmanuelle Weiller, Ross A. Baker, and David V. Sheehan. “Brexpiprazole as an adjunctive treatment in young adults with major depressive disorder who are in a school or work environment..” Journal of Affective Disorders 204 (November 2016): 40–47. https://doi.org/10.1016/j.jad.2016.06.001.
       Full Text
    • Weisler, Richard H., Stuart A. Montgomery, Willie R. Earley, Johan Szamosi, and Arthur Lazarus. “Efficacy of extended release quetiapine fumarate monotherapy in patients with major depressive disorder: a pooled analysis of two 6-week, double-blind, placebo-controlled studies..” International Clinical Psychopharmacology 27, no. 1 (January 2012): 27–39. https://doi.org/10.1097/yic.0b013e32834d6f91.
       Full Text
    • Weisler, Richard H., Joseph R. Calabrese, Charles L. Bowden, John A. Ascher, Joseph DeVeaugh-Geiss, and Gary Evoniuk. “Discovery and development of lamotrigine for bipolar disorder: a story of serendipity, clinical observations, risk taking, and persistence..” Journal of Affective Disorders 108, no. 1–2 (May 2008): 1–9. https://doi.org/10.1016/j.jad.2007.09.012.
       Full Text
    • Weisler, Richard H. “Emerging drugs for attention-deficit/hyperactivity disorder..” Expert Opinion on Emerging Drugs 12, no. 3 (September 2007): 423–34. https://doi.org/10.1517/14728214.12.3.423.
       Full Text
    • Weisler, Richard H. “Review of long-acting stimulants in the treatment of attention deficit hyperactivity disorder..” Expert Opinion on Pharmacotherapy 8, no. 6 (April 2007): 745–58. https://doi.org/10.1517/14656566.8.6.745.
       Full Text
    • Weisler, Richard H., Andrew J. Cutler, James C. Ballenger, Robert M. Post, and Terence A. Ketter. “The use of antiepileptic drugs in bipolar disorders: a review based on evidence from controlled trials..” Cns Spectrums 11, no. 10 (October 2006): 788–99. https://doi.org/10.1017/s1092852900014917.
       Full Text
    • Weisler, Richard H., James G. Barbee, and Mark H. Townsend. “Mental health and recovery in the Gulf Coast after Hurricanes Katrina and Rita..” Jama 296, no. 5 (August 2006): 585–88. https://doi.org/10.1001/jama.296.5.585.
       Full Text
    • Weisler, Richard H., Joseph Biederman, Thomas J. Spencer, Timothy E. Wilens, Stephen V. Faraone, Allan K. Chrisman, Stephanie C. Read, and Simon J. Tulloch. “Mixed amphetamine salts extended-release in the treatment of adult ADHD: a randomized, controlled trial..” Cns Spectrums 11, no. 8 (August 2006): 625–39.
    • Weisler, Richard H. “Carbamazepine extended-release capsules in bipolar disorder..” Neuropsychiatric Disease and Treatment 2, no. 1 (March 2006): 3–11.
    • Weisler, Richard H., Robert Hirschfeld, Andrew J. Cutler, Thomas Gazda, Terence A. Ketter, Paul E. Keck, Alan Swann, Amir Kalali, and Amir SPD417 Study Group. “Extended-release carbamazepine capsules as monotherapy in bipolar disorder : pooled results from two randomised, double-blind, placebo-controlled trials..” Cns Drugs 20, no. 3 (January 2006): 219–31. https://doi.org/10.2165/00023210-200620030-00004.
       Full Text
    • Weisler, Richard H., Joseph Biederman, Thomas J. Spencer, and Timothy E. Wilens. “Long-term cardiovascular effects of mixed amphetamine salts extended release in adults with ADHD..” Cns Spectrums 10, no. 12 Suppl 20 (December 2005): 35–43.
    • Weisler, Richard H. “Carbamazepine extended-release capsules: a new treatment option for bipolar I disorder..” Expert Review of Neurotherapeutics 5, no. 5 (September 2005): 587–95. https://doi.org/10.1586/14737175.5.5.587.
       Full Text
    • Weisler, Richard H. “Safety, efficacy and extended duration of action of mixed amphetamine salts extended-release capsules for the treatment of ADHD..” Expert Opinion on Pharmacotherapy 6, no. 6 (June 2005): 1003–18. https://doi.org/10.1517/14656566.6.6.1003.
       Full Text
    • Weisler, Richard H., Paul E. Keck, Alan C. Swann, Andrew J. Cutler, Terence A. Ketter, Amir H. Kalali, and Amir H. SPD417 Study Group. “Extended-release carbamazepine capsules as monotherapy for acute mania in bipolar disorder: a multicenter, randomized, double-blind, placebo-controlled trial..” The Journal of Clinical Psychiatry 66, no. 3 (March 2005): 323–30.
    • Weisler, Richard H., Amir H. Kalali, Terence A. Ketter, and Terence A. SPD417 Study Group. “A multicenter, randomized, double-blind, placebo-controlled trial of extended-release carbamazepine capsules as monotherapy for bipolar disorder patients with manic or mixed episodes..” The Journal of Clinical Psychiatry 65, no. 4 (April 2004): 478–84.

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.